IPM valued at Rs 9,225 crores in March 2017
Domestic companies continued to dominate the market with a 78 per cent share in March 2017
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Passing the buck?
Prime Minister Modi’s announcement that his government would ensure doctors prescribed generic medicines stirred a hornet’s nest
Express Pharma (Vol. 12, No. 13) May 1-15, 2017
India's Foremost Pharma & Biotech Magazine
The push towards pure generics: Impact on pharma marketing
Mala Raj, Senior Pharma Marketing and Medical Consultant at PMS Services contemplates the consequences of the generic push on some…
Veeva releases survey on digitalisation in Indian pharma
Reports reveals 66 per cent of respondents believe digital will become core to company strategy over the next three years
Health ministry to launch pneumonia vaccine on May 13
In the first phase, the vaccine will be administered under routine immunisation programme in parts of Bihar, Uttar Pradesh and…
Aptar Pharma partners with Kali Care
The partnership aims to develop real-time medication management technology
AstraZeneca boosts early respiratory medicine with Pieris deal
Pieris will be responsible for advancing its preclinical lead candidate, PRS-060, into initial Phase I clinical trials in 2017
Ajanta Pharma posts Rs 114 crore profit after tax in Q4 Fy 2017
The total comprehensive income grew 3 per cent at Rs 113 crore
India has at least 60 million to 80 million people with chronic respiratory disease
As we mark World Asthma Day on May 2, Dr Jaideep A Gogtay, Chief Medical Officer, Cipla explains to Viveka Roychowdhury why unlike…